Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma.

Kiichiro Kaji,Eishiro Mizukoshi,Tatsuya Yamashita,Kuniaki Arai,Hajime Sunagozaka,Kazumi Fushimi,Hidetoshi Nakagawa,Kazutoshi Yamada,Takeshi Terashima,Masaaki Kitahara,Shuichi Kaneko

Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma.

2017

Kiichiro Kaji
Eishiro Mizukoshi
Tatsuya Yamashita
Kuniaki Arai
Hajime Sunagozaka
Kazumi Fushimi
Hidetoshi Nakagawa
Kazutoshi Yamada
Takeshi Terashima
Masaaki Kitahara
Shuichi Kaneko

Background & Aims Squamous cell carcinoma antigen recognized by T cells 3 (SART3), a tumor-associated antigen expressed in many cancers, functions in tumor rejection. In this study, we investigated its usefulness as an immunotherapeutic target in hepatocellular carcinoma (HCC).

Keywords:

Cancer research
Squamous cell carcinoma Antigen
Hepatocellular carcinoma
Immune system
Oncology
Internal medicine
Medicine
Antigen
Immunotherapy
Cytotoxic T cell
SART3
Immunofluorescence
Peripheral blood mononuclear cell

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations